KDR receptor: A key marker defining hematopoietic stem cells

Science

Volumn 285, Issue 5433, 1999, Pages 1553-1558

  Ziegler, B L ^a   Valtieri, M ^b,c   Porada, G Almeida ^d   De Maria, R ^b,c   Muller R ^a   Masella, B ^b   Gabbianelli, M ^c   Casella, I ^b   Pelosi, E ^c   Bock, T ^a   Zanjani, E D ^d   Peschle, C ^b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL FATE; CELL FRACTIONATION; CELL SPECIFICITY; CELL SUBPOPULATION; DILUTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; XENOGRAFT;

ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; FEMALE; FETAL BLOOD; FETUS; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOKINES; MICE; MICE, INBRED NOD; MICE, SCID; PHENOTYPE; PREGNANCY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SHEEP; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0033520341     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.285.5433.1553     Document Type: Article

References (46)

1. M. Ogawa, Blood 81, 2844 (1993).
2. M. Bhatia, J. C. Y. Wang, U. Kapp, D. Bonnet, J. E. Dick, Proc. Natl. Acad. Sci. U.S.A. 94, 5320 (1997); J. C. Y. Wang, M. Doedens, J. E. Dick, Blood 89, 3919 (1997); E. Conneally, J. Cashman, A. Petzer, C. Eaves, Proc. Natl. Acad. Sci. U.S.A. 94, 9836 (1997).
3. M. Bhatia, J. C. Y. Wang, U. Kapp, D. Bonnet, J. E. Dick, Proc. Natl. Acad. Sci. U.S.A. 94, 5320 (1997); J. C. Y. Wang, M. Doedens, J. E. Dick, Blood 89, 3919 (1997); E. Conneally, J. Cashman, A. Petzer, C. Eaves, Proc. Natl. Acad. Sci. U.S.A. 94, 9836 (1997).
4. M. Bhatia, J. C. Y. Wang, U. Kapp, D. Bonnet, J. E. Dick, Proc. Natl. Acad. Sci. U.S.A. 94, 5320 (1997); J. C. Y. Wang, M. Doedens, J. E. Dick, Blood 89, 3919 (1997); E. Conneally, J. Cashman, A. Petzer, C. Eaves, Proc. Natl. Acad. Sci. U.S.A. 94, 9836 (1997).
5. E. D. Zanjani, G. Almeida-Porada, A. G. Livingston, A. W. Flake, M. Ogawa, Exp. Hematol. 26, 353 (1998).
6. J. Brandt, E. F. Srour, K. van Besien, R. A. Briddell, R. Hoffman, J. Clin. Invest. 86, 932 (1990).
7. M. Gabbianelli et al., Science 249, 1561 (1990).
8. H. J. Sutherland, P. M. Lansdorp, D. H. Henckelman, A. C. Eaves, C. J. Eaves, Proc. Natl. Acad. Sci. U.S.A. 87, 3584 (1990).
9. J. C. van der Loo and R. E. Ploemacher, Blood 85, 2598 (1995).
10. A. Larochelle et al., Nature Med. 2, 1329 (1996).
11. Q. L. Hao, F. T. Thiemann, D. Petersen, E. M. Smogorzewska, G. M. Crooks, Blood 88, 3306 (1996).
12. F. Shalaby et al., Cell 89, 981 (1997).
13. W. Risau and I. Flamme, Annu. Rev. Cell Dev. Biol. 11, 73 (1995); A. Eichmann et al., Proc. Natl. Acad. Sci. U.S.A. 94, 5141 (1997).
14. W. Risau and I. Flamme, Annu. Rev. Cell Dev. Biol. 11, 73 (1995); A. Eichmann et al., Proc. Natl. Acad. Sci. U.S.A. 94, 5141 (1997).
15. N. Kabrun et al., Development 124, 2039 (1997); M. Kennedy et al., Nature 386, 488 (1997); S. I. Nishikawa, S. Nishikawa, M. Hirashima, N. Matsuyoshi, H. Kodama, Development 125, 1747 (1998); K. Choi, M. Kennedy, A. Kazarov, J. C. Papadimitriou, G. Keller, ibid., p. 725.
16. N. Kabrun et al., Development 124, 2039 (1997); M. Kennedy et al., Nature 386, 488 (1997); S. I. Nishikawa, S. Nishikawa, M. Hirashima, N. Matsuyoshi, H. Kodama, Development 125, 1747 (1998); K. Choi, M. Kennedy, A. Kazarov, J. C. Papadimitriou, G. Keller, ibid., p. 725.
17. N. Kabrun et al., Development 124, 2039 (1997); M. Kennedy et al., Nature 386, 488 (1997); S. I. Nishikawa, S. Nishikawa, M. Hirashima, N. Matsuyoshi, H. Kodama, Development 125, 1747 (1998); K. Choi, M. Kennedy, A. Kazarov, J. C. Papadimitriou, G. Keller, ibid., p. 725.
18. N. Kabrun et al., Development 124, 2039 (1997); M. Kennedy et al., Nature 386, 488 (1997); S. I. Nishikawa, S. Nishikawa, M. Hirashima, N. Matsuyoshi, H. Kodama, Development 125, 1747 (1998); K. Choi, M. Kennedy, A. Kazarov, J. C. Papadimitriou, G. Keller, ibid., p. 725.
19. T. Asahara et al., Science 275, 964 (1997).
20. O. Katoh, H. Tauchi, K. Kawaishi, A. Kimura, Y. Satow, Cancer Res. 55, 5687 (1995).
21. PB HPCs 90 to 95% pure were grown in unilineage differentiation cultures (31). RT-PCR analysis (16) indicated that KDR mRNA is expressed at low levels in HPCs but is not detected in the HPC progeny except megakaryocytes.
22. + cells. KDR RT-PCR was performed as described (32) with 5′-AAAACCTTTTGTTGCTTTTTGA-3′ and 5′-GAAATGGGATTGGTAAGGATGA-3′ primers (33).
23. E. Broxmeyer et al., Int. J. Hematol. 62, 203 (1995); D. Gabrilovich et al., Blood 92, 4150 (1998).
24. E. Broxmeyer et al., Int. J. Hematol. 62, 203 (1995); D. Gabrilovich et al., Blood 92, 4150 (1998).
25. M. Gabbianelli et al., Blood 86, 1661 (1995).
26. B. L. Ziegler et al., data not shown.
27. - medium ± VEGF (100 ng/ml) was performed as in (32).
28. A. Carè et al., Oncogene 18, 1993 (1999).
29. - cells were injected intravenously together with 100,000 irradiated (20 Gy) BM or CB MCs into the lateral tail vein. Mice were killed 12 weeks after xenotransplantation according to institutional regulations. Cell suspensions from femurs, spleen, and PB were analyzed for human cells by flow cytometry. Erythrocyte-depleted cells were labeled with FITC-or PE-conjugated mAbs directed against the following markers: CD45 (HLe1), CD34 (HPCA-2), CD38, CD15, CD33, CD71, CD2, CD3, CD4, CD7, CD8, CD19, CD20, CD16, CD56 (Becton-Dickinson), GPA, and CD71 (Pharmingen,). FITC-or PE-conjugated isotype-matched irrelevant mAbs were used as controls. BM, spleen, and PB cells from nontransplanted mice were used as negative control. Positive controls consisted of human BM or CB MCs. BM MCs were also cultured in semisolid media selective for human HPCs (20).
30. M. M. Verstegen et al. Blood 91, 1966 (1998).
31. M. Bhatia, D. Bonnet, B. Murdoch, O. I. Gan, J. E. Dick, Nature Med. 4, 1038 (1998).
32. M. E. Garcia-Ojeda, S. Dejbakhsh-Jones, I. L. Weissman, S. Strober, J. Exp. Med. 187, 1813 (1998).
33. + cells, isolated by MiniMACS column from BM MCs (16), were transplanted in secondary recipients.
34. C. I. Civin et al., Blood 88, 4102 (1996).
35. I. Kawashima et al., ibid. 87, 4136 (1996); D. R. Sutherland et al., Exp. Hematol. 24, 795 (1996); N. Uchida et al., Blood 88, 1297 (1996).
36. I. Kawashima et al., ibid. 87, 4136 (1996); D. R. Sutherland et al., Exp. Hematol. 24, 795 (1996); N. Uchida et al., Blood 88, 1297 (1996).
37. I. Kawashima et al., ibid. 87, 4136 (1996); D. R. Sutherland et al., Exp. Hematol. 24, 795 (1996); N. Uchida et al., Blood 88, 1297 (1996).
38. + cell subfraction was analyzed and sorted as in (16).
39. R. J. Berenson et al., J. Clin. Invest. 81, 951 (1988); Blood 77, 1717 (1991); W. I. Bensinger et al., ibid. 88, 4132 (1996); E. D. Zanjani, G. Almeida-Porada, A. W. Flake, Int. J. Hematol. 63, 179 (1996).
40. R. J. Berenson et al., J. Clin. Invest. 81, 951 (1988); Blood 77, 1717 (1991); W. I. Bensinger et al., ibid. 88, 4132 (1996); E. D. Zanjani, G. Almeida-Porada, A. W. Flake, Int. J. Hematol. 63, 179 (1996).
41. R. J. Berenson et al., J. Clin. Invest. 81, 951 (1988); Blood 77, 1717 (1991); W. I. Bensinger et al., ibid. 88, 4132 (1996); E. D. Zanjani, G. Almeida-Porada, A. W. Flake, Int. J. Hematol. 63, 179 (1996).
42. R. J. Berenson et al., J. Clin. Invest. 81, 951 (1988); Blood 77, 1717 (1991); W. I. Bensinger et al., ibid. 88, 4132 (1996); E. D. Zanjani, G. Almeida-Porada, A. W. Flake, Int. J. Hematol. 63, 179 (1996).
43. U. Testa et al., Blood 88, 3391 (1996).
44. B. L. Ziegler et al., ibid. 93, 3355 (1999).
45. B. I. Terman et al., Oncogene 6, 1677 (1991).
46. P. E. Warburton, G. M. Greig, T. Haaf, H. F. Willard, Genomics 11, 324 (1991)